Participated · Equity · May 2024

Ketos is a San Francisco-based water intelligence company offering real-time water analytics and intelligence. Led by CEO and Founder Meena Sankaran, Ketos uses machine learning and predictive technology to measure parts per billion specificity and standardized water metrics to improve efficiency, operations, yield, compliance, and treatment choices. Its solutions combine an industrial-grade, patented robotics system, an IoT communication framework, and an AI-enabled software platform to deliver mission-critical insights and 24/7 services. The company operates across nine countries and plans to use its newly raised capital to advance go-to-market efforts and expand its global presence. Ketos announced $10M in additional equity growth financing to support that expansion and sales strategy. Accenture participates as both an investor and a strategic resale partner, and Ketos added two new board directors and two strategic advisors to support its growth trajectory. Ketos provides a fully integrated, EPA-compliant solution that combines intelligent hardware, stable connectivity infrastructure and an interactive cloud software platform to deliver actionable water-quality and efficiency data. Its system performs real-time monitoring across parameters such as selenium, arsenic, chromium, manganese, iron and nitrates and applies machine learning models to generate predictive intelligence. The platform is positioned for use in chemical treatment optimization, public health monitoring, process control, food processing and effluent discharge compliance. Ketos emphasizes a patented, proprietary approach and intends to use new funding to scale and further advance that solution. The company was launched in 2015 and is headquartered in San Francisco, CA. To date the company has raised $30M in total financing. Ketos provides industrial, agricultural, commercial and institutional customers with a patented sensors and machine-learning analytics platform that delivers actionable, real-time water monitoring and analytics. Its KETOS Shield Fabric offers real-time water safety management with advanced warnings for contaminants and heavy-metal toxins and suggests filtration or remediation actions. The KETOS Wave Fabric delivers real-time water utilization data, leak detection and remote water supply management from inline software, plus predictive insights on distribution, flow and pressure. The platform can directly measure 20+ parameters at lab-precision levels and has analyzed over one million water quality tests across more than one million gallons with 130+ deployments in India, Mexico and the United States. Led by CEO Meena Sankaran, the company will use the Series A proceeds to expand its team and accelerate global market penetration. Energy Innovation’s Veery Maxwell will join the Ketos board as part of the financing.

Participated · Series A · Apr 2023

Mercy BioAnalytics develops extracellular vesicle–based liquid biopsy tests aimed at the early detection of cancer. Its patented Mercy Halo platform uses biomarker co-localization to interrogate abundant blood-based extracellular vesicles that carry cancer signatures from their cell of origin. The company’s initial focus is the early detection of ovarian and lung cancers, and its blood-based ovarian cancer test portfolio is designed to detect pre-clinical high grade serous ovarian carcinoma in post-menopausal women. Mercy says the Mercy Halo ovarian cancer screening test shows unprecedented sensitivity and specificity in a blinded evaluation of samples from a randomized controlled trial. The company plans to commercialize its ovarian cancer tests and expand the Mercy Halo portfolio to include multi-cancer and lung cancer screening tests. Mercy is based in Waltham, Mass., and recently closed a financing to support commercialization and portfolio expansion. Mercy BioAnalytics is advancing the Mercy Halo extracellular vesicle‑based liquid biopsy platform to enable early detection of cancer. Mercy Halo seeks high clinical sensitivity and specificity by simultaneously detecting multiple cancer‑related biomarkers co‑localized on individual tumor‑derived extracellular vesicles. The test can be run on a very small volume of serum or plasma and uses a simple PCR‑based readout. The company closed an oversubscribed $41 million Series A to advance development and commercialization, with an initial focus on high‑risk lung cancer screening. Proceeds will also support clinical programs in ovarian cancer and the development of a broader portfolio of early‑detection tests. Preliminary data presented at ASCO, AACR and EDCC demonstrated promising performance for detecting Stage I and II lung and ovarian cancers, and Mercy is planning larger independent validation studies.

Participated · Seed · Jul 2022

Lisa Health, spun out of SRI International in 2020, develops Midday, an AI-driven app to support women through menopause. The app delivers personalized insights, tracks a user’s stage in the menopause journey, and recommends holistic interventions and symptom treatments. Midday offers users the ability to request virtual care appointments with Mayo Clinic clinicians and provides guidance on hormone therapy eligibility. Lisa Health developed the app under a health license agreement with Mayo Clinic, which provided clinical expertise and continues to advise on evidence-backed approaches. The company is working on a premium version that will include novel technology for hot flash detection and other menopause biomarkers. Midday is available on the app store with a 30-day free trial, then a $29.99 quarterly or $79.99 annual subscription. Lisa Health positions itself against competitors such as Evernow, Vira Health, and Alloy while emphasizing an AI- and physiology-based approach.

Led · Equity · Dec 2021

Interos.ai is an AI-powered supply chain and risk intelligence platform that helps commercial enterprises and U.S. federal agencies identify and mitigate disruptions across global supplier networks. Founded by Jennifer Bisceglie and headquartered in Arlington, Virginia, the software continuously ingests multi-tier supplier data and applies predictive analytics to surface operational, financial, and geopolitical risks. Current customers include Cooper University Health Care, Vantage Data Centers, TD Bank, the Defense Logistics Agency, and the U.S. Navy, illustrating adoption across both private and public sectors. By combining artificial intelligence with real-time analytics, the company positions itself as a critical tool for strengthening supply-chain resilience and ensuring business continuity. With fresh capital, Interos.ai plans to pursue a product-led growth strategy and further enhance its predictive analytics capabilities. The article did not disclose revenue, user, or other operating metrics.

Participated · Series A · Mar 2021

Unagi Scooters is an Oakland-based manufacturer of electric scooters and operator of an e-scooter subscription service. Its All-Access subscription charges a flat $49 monthly fee that includes maintenance and insurance for scooter theft or damage. Subscribers receive the company's Model One scooter delivered to their home via FedEx within 72 hours. Unagi offers service in several U.S. cities including New York City, Los Angeles, Austin, Miami, Nashville, Phoenix, the San Francisco Bay Area and Seattle. The company intends to use new funding to expand the All-Access service, grow the team and increase manufacturing capacity. Unagi makes premium, portable electric scooters designed for urban commuters, emphasizing a balance of weight, range, speed and rideability. Founded in 2018, the company launched via Kickstarter and says it has seen overwhelming demand since. Its scooters weigh about 24 pounds, use dual motors totaling 450 watts, and employ materials like carbon fiber and magnesium with a patented one-click hinge for folding. Unagi highlights features such as puncture-proof 7.5" solid rubber wheels, dual electronic anti-lock brakes, and a sleek integrated command center. The product has received strong media praise — CNET named it the "best all-around e-scooter" and publications including Engadget, Gizmodo, The Verge and Wired have reviewed it favorably. Pricing starts at $840 with installment plans available from about $35 per month.